Future Market Insights opines that the clinical diagnostics market is entering a platform consolidation phase where reagent rental models and menu breadth on high-throughput analysers determine laboratory contract wins, while AI-assisted interpretation and liquid biopsy are creating new revenue layers that shift diagnostic value from sample processing to clinical decision support.